Accessing the European Pharma Market: becoming a MAH through dossier acquisition.

  Positioned as the second largest pharmaceutical market in the world and showing a steady and extensive growth pattern, Europe’s pharma market is becoming increasingly attractive, but accessing this market implies both regulatory and technical requirements, so different strategies need to be considered to ensure cost-effectiveness. One of the options available for companies seeking to…